Indivior Total Long-Term Assets 2012-2025 | INDV

Indivior total long-term assets from 2012 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
Indivior Annual Total Long-Term Assets
(Millions of US $)
2024 $481
2023 $494
2022 $510
2021 $388
2020 $344
2019 $292
2018 $218
2017 $219
2016 $219
2015 $216
2014 $182
2013 $198
2012 $208
2011 $230
Indivior Quarterly Total Long-Term Assets
(Millions of US $)
2025-03-31 $493
2024-12-31 $488
2024-09-30 $665
2024-06-30 $671
2024-03-31 $657
2023-12-31 $494
2023-09-30 $632
2023-06-30 $637
2023-03-31 $633
2022-12-31 $510
2022-09-30 $407
2022-06-30 $379
2022-03-31 $461
2021-12-31 $388
2021-09-30 $386
2021-06-30 $379
2021-03-31 $344
2020-12-31 $344
2020-09-30 $345
2020-06-30 $373
2020-03-31 $349
2019-12-31 $292
2019-09-30 $290
2019-06-30 $297
2019-03-31 $254
2018-12-31 $218
2018-09-30 $261
2018-06-30 $248
2018-03-31 $243
2017-12-31 $219
2017-09-30 $233
2017-06-30 $216
2017-03-31 $191
2016-12-31 $219
2016-09-30 $213
2016-06-30 $202
2016-03-31 $191
2015-12-31 $216
2015-09-30 $177
2015-06-30 $193
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2013-12-31 $222
2012-12-31 $195
2011-12-31 $229
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.000B $1.188B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $77.504B 29.07
Zoetis (ZTS) US $65.610B 24.48
Daiichi Sankyo, - (DSNKY) JP $46.052B 23.60
Takeda Pharmaceutical (TAK) JP $45.947B 9.14
BeOne Medicines - (ONC) KY $31.996B 0.00
Sandoz Group AG (SDZNY) CH $25.212B 0.00
Summit Therapeutics (SMMT) US $19.562B 0.00
Merck (MKKGY) DE $16.608B 12.17
Shionogi (SGIOY) JP $14.377B 14.40
United Therapeutics (UTHR) US $13.222B 11.70
Neurocrine Biosciences (NBIX) US $13.047B 44.69
Orion OYJ (ORINY) FI $10.973B 26.45
IPSEN (IPSEY) FR $10.477B 0.00
Corcept Therapeutics (CORT) US $7.436B 60.45
Madrigal Pharmaceuticals (MDGL) US $7.348B 0.00
Stevanato Group S.p.A (STVN) IT $7.320B 44.76
Grifols, S.A (GRFS) ES $6.876B 0.00
Ionis Pharmaceuticals (IONS) US $6.613B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $6.153B 0.00
Ono Pharmaceutical (OPHLF) JP $5.214B 15.86
Soleno Therapeutics (SLNO) US $4.383B 0.00
Procaps Group, S.A (PROCF) LU $3.202B 0.00
Hypermarcas (HYPMY) BR $3.004B 19.76
Crinetics Pharmaceuticals (CRNX) US $2.898B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.563B 8.98
NewAmsterdam Pharma (NAMS) NL $2.533B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.479B 13.41
Centessa Pharmaceuticals (CNTA) GB $2.145B 0.00
Ocular Therapeutix (OCUL) US $1.834B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.783B 0.00
ARS Pharmaceuticals (SPRY) US $1.753B 0.00
Endo (NDOI) US $1.656B 0.00
Harrow (HROW) US $1.360B 0.00
Guardian Pharmacy Services (GRDN) US $1.322B 0.00
Evotec AG (EVO) DE $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.165B 23.30
Enliven Therapeutics (ELVN) US $1.073B 0.00
Avadel Pharmaceuticals (AVDL) IE $1.062B 0.00
Ardelyx (ARDX) US $1.058B 0.00
Dyne Therapeutics (DYN) US $1.042B 0.00
Akebia Therapeutics (AKBA) US $1.009B 0.00
Collegium Pharmaceutical (COLL) US $0.993B 5.36
Verve Therapeutics (VERV) US $0.974B 0.00
ProKidney (PROK) US $0.942B 0.00
Cronos Group (CRON) CA $0.806B 0.00
Xeris Biopharma Holdings (XERS) US $0.804B 0.00
KalVista Pharmaceuticals (KALV) US $0.777B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.732B 0.00
Xencor (XNCR) US $0.648B 0.00
Zevra Therapeutics (ZVRA) US $0.641B 0.00
Relay Therapeutics (RLAY) US $0.622B 0.00
Organogenesis (ORGO) US $0.578B 0.00
Elite Pharmaceuticals (ELTP) US $0.569B 0.00
Theravance Biopharma (TBPH) US $0.568B 0.00
USANA Health Sciences (USNA) US $0.564B 12.26
Bioventus (BVS) US $0.518B 13.12
Oruka Therapeutics (ORKA) US $0.516B 0.00
Siga Technologies (SIGA) US $0.489B 10.22
Tourmaline Bio (TRML) US $0.468B 0.00
Aquestive Therapeutics (AQST) US $0.420B 0.00
Savara (SVRA) US $0.396B 0.00
Rigel Pharmaceuticals (RIGL) US $0.350B 9.46
Tonix Pharmaceuticals Holding (TNXP) US $0.332B 0.00
Altimmune (ALT) US $0.328B 0.00
Aldeyra Therapeutics (ALDX) US $0.323B 0.00
Nektar Therapeutics (NKTR) US $0.308B 0.00
AleAnna (ANNA) US $0.300B 0.00
Heron Therapeutics (HRTX) US $0.293B 0.00
Nature's Sunshine Products (NATR) US $0.273B 25.08
OmniAb (OABI) US $0.242B 0.00
Nanobiotix S.A (NBTX) FR $0.241B 0.00
Esperion Therapeutics (ESPR) US $0.228B 0.00
MediWound (MDWD) IL $0.217B 0.00
Larimar Therapeutics (LRMR) US $0.209B 0.00
4D Molecular Therapeutics (FDMT) US $0.196B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.188B 0.00
Aclaris Therapeutics (ACRS) US $0.178B 0.00
Galectin Therapeutics (GALT) US $0.173B 0.00
Journey Medical (DERM) US $0.168B 0.00
Profound Medical (PROF) CA $0.167B 0.00
Liminatus Pharma (LIMN) US $0.145B 0.00
Lyell Immunopharma (LYEL) US $0.141B 0.00
Inhibikase Therapeutics (IKT) US $0.140B 0.00
Avita Medical (RCEL) US $0.138B 0.00
Protara Therapeutics (TARA) US $0.132B 0.00
Lexeo Therapeutics (LXEO) US $0.131B 0.00
Korro Bio (KRRO) US $0.125B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.124B 0.00
Cassava Sciences (SAVA) US $0.111B 0.00
Champions Oncology (CSBR) US $0.111B 18.25
Innate Pharma SA (IPHYF) FR $0.110B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.105B 0.00
Cardiol Therapeutics (CRDL) CA $0.101B 0.00
VAXART, INC (VXRT) US $0.097B 0.00
Achieve Life Sciences (ACHV) CA $0.092B 0.00
Vivani Medical (VANI) US $0.092B 0.00
Nutriband (NTRB) US $0.092B 0.00
Fractyl Health (GUTS) US $0.088B 0.00
Wellgistics Health (WGRX) US $0.085B 0.00
Arch Biopartners (ACHFF) CA $0.084B 0.00
ESSA Pharma (EPIX) CA $0.083B 0.00
Metagenomi (MGX) US $0.081B 0.00
Context Therapeutics (CNTX) US $0.078B 0.00
Dominari Holdings (DOMH) US $0.076B 0.00
Surrozen (SRZN) US $0.074B 0.00
Rafael Holdings (RFL) US $0.074B 0.00
Avalo Therapeutics (AVTX) US $0.073B 0.00
Verrica Pharmaceuticals (VRCA) US $0.071B 0.00
Pyxis Oncology (PYXS) US $0.070B 0.00
PMV Pharmaceuticals (PMVP) US $0.070B 0.00
Assertio Holdings (ASRT) US $0.067B 0.00
Telomir Pharmaceuticals (TELO) US $0.066B 0.00
Inotiv (NOTV) US $0.059B 0.00
Jupiter Neurosciences (JUNS) US $0.059B 0.00
Allergy Therapeutics (AGYTF) GB $0.059B 0.00
Unicycive Therapeutics (UNCY) US $0.057B 0.00
Klotho Neurosciences (KLTO) US $0.055B 0.00
ElectroCore (ECOR) US $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.052B 38.89
NRx Pharmaceuticals (NRXP) US $0.052B 0.00
Century Therapeutics (IPSC) US $0.050B 0.00
Prelude Therapeutics (PRLD) US $0.048B 0.00
Gain Therapeutics (GANX) US $0.048B 0.00
Acrivon Therapeutics (ACRV) US $0.044B 0.00
Mural Oncology (MURA) IE $0.043B 0.00
PolyPid (PYPD) IL $0.038B 0.00
Iterum Therapeutics (ITRM) IE $0.035B 0.00
Karyopharm Therapeutics (KPTI) US $0.035B 0.00
Vivos Therapeutics (VVOS) US $0.032B 0.00
FibroGen (FGEN) US $0.031B 0.00
Enlivex Therapeutics (ENLV) IL $0.028B 0.00
Scienture Holdings (SCNX) US $0.028B 0.00
SCYNEXIS (SCYX) US $0.028B 0.00
Incannex Healthcare (IXHL) AU $0.024B 0.00
Tempest Therapeutics (TPST) US $0.023B 0.00
Natural Alternatives (NAII) US $0.021B 0.00
Relmada Therapeutics (RLMD) US $0.020B 0.00
Plus Therapeutics (PSTV) US $0.020B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.019B 0.00
BioLineRx (BLRX) IL $0.019B 0.00
VYNE Therapeutics (VYNE) US $0.018B 0.00
DURECT (DRRX) US $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.017B 0.00
Lipocine (LPCN) US $0.017B 0.00
ProPhase Labs (PRPH) US $0.017B 0.00
Carisma Therapeutics (CARM) US $0.016B 0.00
Mannatech (MTEX) US $0.015B 0.00
Citius Pharmaceuticals (CTXR) US $0.015B 0.00
CASI Pharmaceuticals (CASI) CN $0.015B 0.00
Ernexa Therapeutics (ERNA) US $0.014B 0.00
Cosmos Health (COSM) US $0.014B 0.00
BioVie (BIVI) US $0.014B 0.00
Minerva Neurosciences (NERV) US $0.014B 2.37
TherapeuticsMD (TXMD) US $0.013B 0.00
Phio Pharmaceuticals (PHIO) US $0.011B 0.00
Ainos (AIMD) US $0.011B 0.00
Lyra Therapeutics (LYRA) US $0.011B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.010B 0.00
Kiora Pharmaceuticals (KPRX) US $0.009B 0.00
Aptorum Group (APM) GB $0.009B 0.00
Traws Pharma (TRAW) US $0.009B 0.00
Biomerica (BMRA) US $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
TransCode Therapeutics (RNAZ) US $0.008B 0.00
NLS Pharmaceutics (NLSP) CH $0.008B 0.00
Nuvilex (PMCB) US $0.007B 0.00
Indaptus Therapeutics (INDP) US $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.006B 0.00
Xenetic Biosciences (XBIO) US $0.006B 0.00
Redhill Biopharma (RDHL) IL $0.005B 0.00
InMed Pharmaceuticals (INM) CA $0.005B 0.00
Alaunos Therapeutics (TCRT) US $0.005B 0.00
Qualigen Therapeutics (QLGN) US $0.005B 0.00
Quoin Pharmaceuticals (QNRX) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.005B 0.00
SciSparc (SPRC) IL $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
SHINECO (SISI) CN $0.003B 0.00
CERo Therapeutics Holdings (CERO) US $0.003B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.003B 0.00
PainReform (PRFX) IL $0.003B 0.00
Heatwurx (PCSA) US $0.003B 0.00
Aditxt (ADTX) US $0.003B 0.00
Jaguar Animal Health (JAGX) US $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
Conduit Pharmaceuticals (CDT) US $0.002B 0.00
Salarius Pharmaceuticals (SLRX) US $0.002B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
4D Pharma (LBPS) GB $0.000B 0.00
MEI Pharma (MEIP) US $0.000B 0.00
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00